1 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed, Vol 2. IARC/WHO;2017.
2 Shimada K, Kinoshita T, Naoe T, Nakamura S. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol. 2009;10(9):895–902.
3 Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25(21):3168–73.
4 Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M, et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008;26(19):3189–95.
5 Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the «cutaneous variant». Br J Haematol. 2004;127(2):173–83.
6 Matsue K, Asada N, Odawara J, Aoki T, Kimura S, Iwama K, et al. Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. Ann Hematol. 2011;90(4):417–21.
7 Jillella A, Day DS, Severson K, Kallab A, Burgess R. Non-Hodgkin’s Lymphoma presenting as anasarca: probably mediated by tumor necrosis factor alpha (TNF-a). Leuk Lymphoma. 2000;38(3–4):419–22.
8 Pothen L, Rouvière H, Poncin R, Michaux L, Damoiseau P, Lambert M. Systemic capillary leak syndrome revealing a diffuse large B-cell lymphoma. Acta Clin Belg. 2014;69(4):305–8.